History
# Registration date Revision Id
2 2026-09-26, 1405/07/04 401662
1 2024-09-26, 1403/07/05 315337
Changes made to previous revision
  • Help:

    Red color represents old content. It may be empty showing addition in the new version.
    Green color represents new content. It may be empty showing deletion in the new version.

    Inline Side by side
    Added new contents, deleted old contents, contents that are not changed.
    New table contents New table contents
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    Added new contents, contents that are not changed.
    Deleted old contents, contents that are not changed.
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    New table contents New table contents
    Unchanged contents Unchanged contents
  • Protocol summary

    The conditions for entering the study include the following: Men and women aged 18 - 65 with hyper mobility musculoskeletal pain in minimum one shoulder for at least three months and/or recurrent joint dislocations or joint instability without a reported history of trauma The following people are not eligible: Clinically suspected referred pain from the cervical spine Systemic inflammatory rheumatic diseases Connective tissue diseases e.g. Marfans, Stickler's or Loeys Dietz syndromes, Ehlers-Danlos Syndromes except hypermobile type Neurological diseases Pregnancy Steroid injection in the affected shoulder within three months
    The conditions for entering the study include the following: Women aged 18 - 65 with hyper mobility musculoskeletal pain in minimum one shoulder for at least three months and/or recurrent joint dislocations or joint instability without a reported history of trauma The following people are not eligible: Clinically suspected referred pain from the cervical spine Systemic inflammatory rheumatic diseases Connective tissue diseases e.g. Marfans, Stickler's or Loeys Dietz syndromes, Ehlers-Danlos Syndromes except hypermobile type Neurological diseases Pregnancy Steroid injection in the affected shoulder within three months
    شرایط ورود به مطالعه شامل موارد زیر می باشد: مردان و زنان بین 18 تا 65 سال که واجد شرایط معیارهای هایپرموبیلیتی شانه. شدت علائم و درد اسکلتی عضلانی حداقل به مدت سه ماه در یک شانه بدون هیچ‌گونه قطعی یا دررفتگی مکرر مفصل یا بی‌ثباتی مفصل بدون سابقه گزارش‌شده از آسیب افرا زیر واجد شرایط نیستند: درد ستون فقرات گردنی تشخیص بیماری سیستمیک رماتیسم التهابی بیماری‌های بافت همبند مانند مارفان، سندرم استیکلر یا لویز دیتز، سندرم اهلرز دانلوس به جز نوع هایپرموبیل بیماری‌های عصبی افرادی که در سه ماه گذشته تزریق استروئید در شانه آسیب‌دیده داشته‌اند. افرادی که جراحی شانه در یک سال گذشته داشته‌اند. زنان باردار
    شرایط ورود به مطالعه شامل موارد زیر می باشد: زنان بین 18 تا 65 سال که واجد شرایط معیارهای هایپرموبیلیتی شانه. شدت علائم و درد اسکلتی عضلانی حداقل به مدت سه ماه در یک شانه بدون هیچ‌گونه قطعی یا دررفتگی مکرر مفصل یا بی‌ثباتی مفصل بدون سابقه گزارش‌شده از آسیب افرا زیر واجد شرایط نیستند: درد ستون فقرات گردنی تشخیص بیماری سیستمیک رماتیسم التهابی بیماری‌های بافت همبند مانند مارفان، سندرم استیکلر یا لویز دیتز، سندرم اهلرز دانلوس به جز نوع هایپرموبیل بیماری‌های عصبی افرادی که در سه ماه گذشته تزریق استروئید در شانه آسیب‌دیده داشته‌اند. افرادی که جراحی شانه در یک سال گذشته داشته‌اند. زنان باردار
  • General information

    Both
    Female
    Factorial
    Parallel
    47
    45
    empty
    45
    empty
    2024-11-09, 1403/08/19
    empty
    2025-01-19, 1403/10/30
    empty
    2025-02-15, 1403/11/27
    empty
    This update is performed to correct several inaccuracies in the original registration and to align the trial record with the final protocol and completed study. The main corrections include: (1) changing the gender of participants from “Both” to “Female” because only women were enrolled; (2) updating the inclusion and exclusion criteria to accurately reflect the final eligibility criteria used in the study; (3) correcting the randomization description, blinding status, and allocation concealment details; (4) changing the study design assignment from Factorial to Parallel; (5) updating the sample size (target and actual) to 45 participants; (6) correcting the ethics committee information; and (7) revising the primary and secondary outcome descriptions, intervention details, and other design features to match the actual conducted trial and the published manuscript.
    empty
    این به‌روزرسانی به منظور اصلاح چندین مورد نادرست در ثبت اولیه و همسو کردن رکورد کارآزمایی با پروتکل نهایی و مطالعه انجام‌شده صورت می‌گیرد. اصلاحات اصلی عبارتند از: (۱) تغییر جنسیت شرکت‌کنندگان از «هر دو جنس» به «زن» زیرا فقط زنان وارد مطالعه شدند؛ (۲) به‌روزرسانی معیارهای ورود و خروج برای انطباق دقیق با معیارهای نهایی استفاده شده در مطالعه؛ (۳) اصلاح شرح تصادفی‌سازی، وضعیت کورسازی و جزئیات پنهان‌سازی تخصیص؛ (۴) تغییر نوع تخصیص مطالعه از Factorial به Parallel؛ (۵) به‌روزرسانی حجم نمونه (هدف و واقعی) به ۴۵ شرکت‌کننده؛ (۶) اصلاح اطلاعات کمیته اخلاق؛ و (۷) بازنگری شرح پیامدهای اولیه و ثانویه، جزئیات مداخلات و سایر ویژگی‌های طراحی مطالعه برای انطباق با کارآزمایی واقعی انجام‌شده و نسخه نهایی مقاله.
    Men and women aged 18 - 65
    Generalized HSD (G-HSD) defined with Beighton score cut-off ≥ 5 for women up to the age of 50 years and ≥ 4 for those above 50 years and all men, if the Beighton score was 1 point below the age and sex-specific cut-off AND the five-part questionnaire (5PQ) was positive (= at least two positive items).
    Present with one or more secondary symptomatic musculoskeletal manifestations, defined as either musculoskeletal pain in minimum one shoulder for at least three months and/or recurrent joint dislocations or joint instability without a reported history of trauma defined as either a) minimum three atraumatic dislocations in same shoulder, b) minimum two atraumatic dislocations in two different joints (minimum one in the shoulder) occurring at different times, or c) medical confirmation of joint instability in minimum two joints (minimum one in the shoulder) not related to trauma.
    Women aged 18–65 years
    Generalized joint hypermobility (GJH) defined by Beighton score:– ≥ 5 for women aged ≤ 50 years– ≥ 4 for women aged > 50 years– or one point below the age-specific cutoff when the five-part questionnaire (5PQ) is positive (at least two positive items)
    Presence of one or more of the following secondary symptomatic musculoskeletal manifestations:– Musculoskeletal pain in at least one shoulder for a minimum of three months– and/or recurrent atraumatic joint dislocation or joint instability involving at least two joints (including at least one shoulder), defined as any of the following:• At least three atraumatic dislocations of the same shoulder• At least two atraumatic dislocations in two different joints (including at least one shoulder) occurring at separate times• Medically confirmed joint instability in at least two joints (including at least one shoulder) not related to trauma
    مردان و زنان بین 18 تا 65 سال که واجد شرایط معیارهای هایپرموبیلیتی شانه می باشند که با مثبت شدن تست بیتون که شامل گرفتن نمره چهار برای همه‌ی مردان و زنان بالای 50 سال و نمره‌ی پنج برای زنان کمتر از 50 سال انتخاب می شوندو یک امتیاز کمتر برای بیمارانی که نتایج پرسشنامه‌ی معتبر پنج ‌قسمتی 5PQ آن‌ها مثبت شده است(حداقل دو آیتم مثبت). با یک یا چند علائم اسکلتی عضلانی علامت دار ، که به عنوان درد اسکلتی عضلانی در حداقل یک شانه برای حداقل سه ماه بدون قطعی تعریف می شود یا دررفتگی مکرر مفصل یا بی‌ثباتی مفصل بدون سابقه گزارش‌شده از آسیب 1) حداقل سه دررفتگی کم تهاجمی در همان شانه 2) حداقل دو دررفتگی کم تهاجمی در دو مفصل مختلف (حداقل یک دررفتگی در شانه). بی‌ثباتی مفصل حداقل در دو مفصل (حداقل در یک شانه).
    زنان ۱۸ تا ۶۵ سال
    هایپرموبیلیتی عمومی مفصل (GJH) بر اساس نمره بیتون:– ≥ ۵ برای زنان ≤ ۵۰ سال– ≥ ۴ برای زنان > ۵۰ سال– یا یک امتیاز کمتر از آستانه سنی در صورتی که پرسشنامه پنج‌قسمتی (5PQ) مثبت باشد (حداقل دو آیتم مثبت)
    وجود یک یا چند مورد از تظاهرات اسکلتی-عضلانی علامت‌دار ثانویه:– درد اسکلتی-عضلانی در حداقل یک شانه به مدت حداقل سه ماه– و/یا دررفتگی مکرر بدون تروما یا بی‌ثباتی مفصل در حداقل دو مفصل (شامل حداقل یک شانه)، که به یکی از صورت‌های زیر تعریف می‌شود:• حداقل سه دررفتگی بدون تروما در همان شانه• حداقل دو دررفتگی بدون تروما در دو مفصل مختلف (شامل حداقل یک شانه) در زمان‌های جداگانه• تأیید پزشکی بی‌ثباتی مفصل در حداقل دو مفصل (شامل حداقل یک شانه) که مرتبط با تروما نباشد
    Clinically suspected referred pain from the cervical spine
    Systemic inflammatory rheumatic diseases
    Connective tissue diseases (e.g. Marfans, Stickler's or Loeys Dietz syndromes, Ehlers-Danlos Syndromes except hypermobile type)
    Neurological diseases
    Pregnancy or childbirth within the past year or planning to get pregnant during the study period
    Shoulder surgery within the past year
    Steroid injection in the affected shoulder within three months
    Inability to speak
    Unable to comply with protocol
    Clinically suspected referred pain from the cervical spine
    Systemic inflammatory rheumatic disease
    Heritable connective tissue disorders (e.g., Marfan, Stickler, or Loeys–Dietz syndromes)
    Neurological disorders
    Pregnancy, childbirth within the previous 12 months, or plans to become pregnant during the study
    Corticosteroid injection into the affected shoulder within the previous 3 months
    Shoulder surgery within the previous 12 months
    Inability to communicate verbally
    Inability or unwillingness to comply with the study protocol or provide informed consent
    درد ستون فقرات گردنی
    تشخیص بیماری سیستمیک رماتیسم التهابی
    بیماری‌های بافت همبند مانند مارفان، سندرم استیکلر یا لویز دیتز، سندرم اهلرز دانلوس به جز نوع هایپرموبیل
    بیماری‌های عصبی
    به دلیل افزایش دوره استراحت، افراد باردار یا افرادی که در یک سال گذشته زایمان کرده‌اند.
    افرادی که جراحی شانه در یک سال گذشته داشته‌اند.
    افرادی که در سه ماه گذشته تزریق استروئید در شانه آسیب‌ دیده داشته‌اند.
    ناتوانی در صحبت کردن
    ناتوانی در رعایت پروتکل مطالعه
    درد ارجاعی مشکوک از ستون فقرات گردنی
    بیماری روماتیسمی التهابی سیستمیک
    بیماری‌های بافت همبند ارثی (مانند مارفان، استیکلر یا لویز–دیتز)
    اختلالات عصبی
    بارداری، زایمان در ۱۲ ماه گذشته یا قصد بارداری در طول مطالعه
    تزریق کورتیکواستروئید در شانه مبتلا در ۳ ماه گذشته
    جراحی شانه در ۱۲ ماه گذشته
    ناتوانی در ارتباط کلامی
    ناتوانی یا عدم تمایل به رعایت پروتکل مطالعه یا ارائه رضایت آگاهانه
    The sample size is divided using G-POWER software - randomization method by choosing numbers from 1 to 45 (prepared by the trainer in advance and placed in sealed envelopes in the box) - research The present semi-experimental study was conducted in three groups - one blind strain - with a pre-test-post-test research design with two intervention groups and one control group.
    This was a single-blind (assessor-blinded), three-arm, parallel-group randomized controlled trial with a pre-test–post-test design. An a priori sample size calculation was performed using G*Power software for a repeated-measures ANOVA (group-by-time interaction as the effect of interest), assuming a medium effect size (Cohen’s f = 0.25), α = 0.05, 80% power, three groups and two measurement occasions. The required sample size was estimated at 42 participants; 45 participants (15 per group) were enrolled.
    حجم نمونه با استفاده از نرم افزار G-POWER - تصادفی سازی آزمودنی‌ها با انتخاب اعداد از 1 تا 45 (که توسط مربی از قبل تهیه می شود و در پاکت های در بسته در جعبه قرار داده شده می شود)، تقسیم می شوند- تحقیق نیمه تجربی حاضر سه گروهی -یک سویه کور- با طرح تحقیق به صورت پیش آزمون_پس آزمون با دو گروه مداخله و یک گروه کنترل انجام می شود.
    این مطالعه یک کارآزمایی کنترل‌شده تصادفی سه بازویی موازی، تک‌کور (ارزیاب کور) با طرح پیش‌آزمون-پس‌آزمون بود. محاسبه حجم نمونه پیش از شروع مطالعه با استفاده از نرم‌افزار G*Power برای ANOVA با اندازه‌گیری‌های تکراری (اثر متقابل گروه × زمان) انجام شد. با فرض اندازه اثر متوسط (Cohen’s f = 0.25)، سطح معنی‌داری ۰٫۰۵، توان ۸۰٪، سه گروه و دو زمان اندازه‌گیری، حجم نمونه مورد نیاز ۴۲ نفر برآورد شد و در نهایت ۴۵ شرکت‌کننده (۱۵ نفر در هر گروه) وارد مطالعه شدند.حجم نمونه با استفاده از نرم افزار G-POWER - تصادفی سازی آزمودنی‌ها با انتخاب اعداد از 1 تا 45 (که توسط مربی از قبل تهیه می شود و در پاکت های در بسته در جعبه قرار داده شده می شود)، تقسیم می شوند- تحقیق نیمه تجربی حاضر سه گروهی -یک سویه کور- با طرح تحقیق به صورت پیش آزمون_پس آزمون با دو گروه مداخله و یک گروه کنترل انجام می شود.
    The method of randomly selecting participants involves choosing numbers from 1 to 45, which are prepared in advance by the instructor and placed in sealed envelopes in a box. The randomization sequence remains concealed until the completion of the baseline assessments of the patients.
    Eligible participants were randomly allocated in a 1:1:1 ratio to one of three groups using numbers from 1 to 45 prepared in advance by the treating instructor and placed in sealed opaque envelopes in a box. The randomization sequence remained concealed until completion of each participant’s baseline assessment, at which point the corresponding envelope was opened. A project manager not involved in outcome assessment or treatment delivery oversaw allocation concealment.
    شیوه تصادفی انتخاب شدن آزمودنی ‌ها با انتخاب اعداد از 1 تا 45 (که توسط مربی از قبل تهیه می شود و در پاکت های در بسته در جعبه قرار داده)، تقسیم می شوند. توالی تصادفی سازی تا زمان اتمام ارزیابی های پایه بیماران، فاش نمی شود.
    تخصیص تصادفی ۱:۱:۱ به سه گروه با استفاده از اعداد ۱ تا ۴۵ که از قبل توسط مربی درمان‌کننده تهیه و در پاکت‌های دربسته و مات در یک جعبه قرار داده شده بود. توالی تصادفی‌سازی تا تکمیل ارزیابی پایه هر شرکت‌کننده مخفی ماند و سپس پاکت مربوطه باز شد. مدیر پروژه (که در ارزیابی پیامد یا اجرای درمان دخالت نداشت) بر پنهان‌سازی تخصیص نظارت داشت.
    The evaluator (Outcome Assessor) is blinded to the allocation of groups so that the results are unbiased and accurate.The three groups in the study are supervised by a corrective movement instructor.
    This was a single-blind (assessor-blinded) trial. The outcome assessor who performed all baseline and post-intervention assessments remained blinded to group allocation throughout the study. Participants and the treating instructor could not be blinded due to the nature of the interventions (exercise and education). Participants were instructed not to disclose their group assignment during follow-up testing.
    ارزیاب(ارزیابی کننده پیامد) نسبت به تخصیص گروه‌ها کور می باشد تا نتایج بی طرفانه و دقیق باشد. سه گروه حاضر در مطالعه را یک مربی حرکات اصلاحی زیر نظر دارد.
    این مطالعه به صورت تک‌کور (ارزیاب کور) انجام شد. ارزیاب پیامد که تمام ارزیابی‌های پایه و پس از مداخله را انجام داد، در طول مطالعه نسبت به تخصیص گروهی شرکت‌کنندگان کور بود. به دلیل ماهیت مداخلات (تمرین و آموزش)، شرکت‌کنندگان و مربی درمان‌کننده امکان کور شدن نداشتند. به شرکت‌کنندگان دستور داده شد که در ارزیابی‌های پیگیری، تخصیص گروهی خود را فاش نکنند.
  • Ethics committees

    #1
    2023-09-28, 1402/07/06
    2023-09-20, 1402/06/29
    SSRI.REC-2307-2346
    IR.SSRC.REC.1402.146
  • Health conditions studied

    #1
    Other diso
    empty
    XIII Diseases of the musculoskeletal system and connective tissue
    empty
    Shoulder hypermobility disorder
    Hypermobility spectrum disorder (HSD) with chronic shoulder symptoms / Shoulder hypermobility spectrum disorder
    اختلال طیف هایپر موبیلیتی شانه
    اختلال طیف هایپرموبیلیتی (HSD) همراه با علائم مزمن شانه / اختلال طیف هایپرموبیلیتی شانه
  • Primary outcomes

    #1
    Adding pain neuroscience education to high-load strengthening exercises - clinical and functional variables (pain, strength, range of motion, fear of movement, shoulder function) in shoulder hyper mobility spectrum disorder
    Shoulder-specific symptoms and functional disability
    اضافه کردن آموزش علوم اعصاب درد به تمرینات تقویتی با آستانه‌بالا-متغیرهای بالینی وعملکردی(درد، قدرت، دامنه حرکتی، ترس از حرکت، عملکرد شانه) در اختلال طیف هایپر موبیلیتی شانه
    علائم و ناتوانی عملکردی اختصاصی شانه
    It is measured before the start and after 16 weeks.
    Baseline (before intervention) and immediately after the 16-week intervention
    قبل از شروع و پس از 16 هفته اندازه گیری می شود.
    قبل از شروع مداخله (پایه) و بلافاصله پس از پایان مداخله ۱۶ هفته‌ای
    Western Ontario Questionnaire to assess the individual's self-report of joint laxity and instability - Hand-held dynamometer to measure muscle strength - Numerical pain rating scale to assess pain intensity - Goniometer to measure range of motion - Fear of movement questionnaire to assess fear of movement
    Western Ontario Shoulder Instability Index questionnaire (21 items, total score ranging from 0 to 2100)
    پرسشنامه آنتاریوی غربی جهت ازیابی گزارش خود فرد از عملکرد شلی و بی‌ثباتی مفصل - دینامومتر دستی برای اندازه گیری قدرت عضلات -مقیاس نرخ بندي عددي درد جهت ارزیابی شدت درد - گونیامتر جهت سنجش دامنه حرکتی-پرسشنامه ترس از حرکت براي ارزیابی ترس از حرکت
    پرسشنامه شاخص بی‌ثباتی شانه انتاریو غربی (۲۱ آیتم، نمره کل از ۰ تا ۲۱۰۰)
  • Secondary outcomes

    #1
    empty
    Shoulder pain intensity
    empty
    شدت درد شانه
    empty
    Baseline (before intervention) and immediately after the 16-week intervention
    empty
    قبل از شروع مداخله (پایه) و بلافاصله پس از پایان مداخله ۱۶ هفته‌ای
    empty
    Numerical Pain Rating Scale (score range 0 to 10)
    empty
    مقیاس رتبه‌بندی عددی درد (دامنه نمره از ۰ تا ۱۰)
    #2
    empty
    Shoulder internal rotation muscle strength
    empty
    قدرت عضلانی چرخش داخلی شانه
    empty
    Baseline (before intervention) and immediately after the 16-week intervention
    empty
    قبل از شروع مداخله (پایه) و بلافاصله پس از پایان مداخله ۱۶ هفته‌ای
    empty
    Hand-held dynamometer (force measured in kilograms)
    empty
    دینامومتر دستی (نیرو بر حسب کیلوگرم)
    #3
    empty
    Shoulder external rotation muscle strength
    empty
    قدرت عضلانی چرخش خارجی شانه
    empty
    Baseline (before intervention) and immediately after the 16-week intervention
    empty
    قبل از شروع مداخله (پایه) و بلافاصله پس از پایان مداخله ۱۶ هفته‌ای
    empty
    Hand-held dynamometer (force measured in kilograms)
    empty
    دینامومتر دستی (نیرو بر حسب کیلوگرم)
    #4
    empty
    Shoulder internal rotation range of motion
    empty
    دامنه حرکتی چرخش داخلی شانه
    empty
    Baseline (before intervention) and immediately after the 16-week intervention
    empty
    قبل از شروع مداخله (پایه) و بلافاصله پس از پایان مداخله ۱۶ هفته‌ای
    empty
    Universal goniometer (measured in degrees)
    empty
    گونیامتر جهانی (اندازه‌گیری بر حسب درجه)
    #5
    empty
    Shoulder external rotation range of motion
    empty
    دامنه حرکتی چرخش خارجی شانه
    empty
    Baseline (before intervention) and immediately after the 16-week intervention
    empty
    قبل از شروع مداخله (پایه) و بلافاصله پس از پایان مداخله ۱۶ هفته‌ای
    empty
    Universal goniometer (measured in degrees)
    empty
    گونیامتر جهانی (اندازه‌گیری بر حسب درجه)
    #6
    empty
    Fear of movement
    empty
    ترس از حرکت
    empty
    Baseline (before intervention) and immediately after the 16-week intervention
    empty
    قبل از شروع مداخله (پایه) و بلافاصله پس از پایان مداخله ۱۶ هفته‌ای
    empty
    Tampa Scale of Kinesiophobia-11 questionnaire
    empty
    پرسشنامه مقیاس ترس از حرکت تامپا نسخه ۱۱ آیتمی
  • Sponsors / Funding sources

    #1
    Private
    Public
    Persons
    Academic
    Pardis Garouee
    No external funding (Kharazmi University provided academic facilities)
    پردیس گرویی
    بدون بودجه خارجی (دانشگاه خوارزمی امکانات دانشگاهی را فراهم کرده است)

Protocol summary

Study aim
The general aim of the research is to compare the equivalence of adding pain neuroscience education to high-load strengthening exercises on clinical and functional outcomes of participants with hyper mobility spectrum disorder.
Design
The sample size is divided using G-POWER software - randomization method by choosing numbers from 1 to 45 (prepared by the trainer in advance and placed in sealed envelopes in the box) - research The present semi-experimental study was conducted in three groups - one blind strain - with a pre-test-post-test research design with two intervention groups and one control group.
Settings and conduct
It is done as a blind strain (outcome Assessor) in a sports club for 16 weeks.
Participants/Inclusion and exclusion criteria
The conditions for entering the study include the following: Women aged 18 - 65 with hyper mobility musculoskeletal pain in minimum one shoulder for at least three months and/or recurrent joint dislocations or joint instability without a reported history of trauma The following people are not eligible: Clinically suspected referred pain from the cervical spine Systemic inflammatory rheumatic diseases Connective tissue diseases e.g. Marfans, Stickler's or Loeys Dietz syndromes, Ehlers-Danlos Syndromes except hypermobile type Neurological diseases Pregnancy Steroid injection in the affected shoulder within three months
Intervention groups
Group 1: high-load strengthening exercises, group 2: combination of pain neuroscience education interventions and high-load strengthening exercises, group 3: control group (ergonomic recommendations and anatomy/physiology training).
Main outcome variables
Independent variable: pain neuroscience education and high-load strengthening exercises. Dependent variable: pain, self-report of joint laxity and instability, strength, shoulder range of motion, fear of movement.

General information

Reason for update
This update is performed to correct several inaccuracies in the original registration and to align the trial record with the final protocol and completed study. The main corrections include: (1) changing the gender of participants from “Both” to “Female” because only women were enrolled; (2) updating the inclusion and exclusion criteria to accurately reflect the final eligibility criteria used in the study; (3) correcting the randomization description, blinding status, and allocation concealment details; (4) changing the study design assignment from Factorial to Parallel; (5) updating the sample size (target and actual) to 45 participants; (6) correcting the ethics committee information; and (7) revising the primary and secondary outcome descriptions, intervention details, and other design features to match the actual conducted trial and the published manuscript.
Acronym
Pain Neuroscience Education (PNE) ,Hyper mobility spectrum disorder (HSD)
IRCT registration information
IRCT registration number: IRCT20231118060102N1
Registration date: 2024-09-26, 1403/07/05
Registration timing: prospective

Last update: 2026-10-31, 1405/08/09
Update count: 1
Registration date
2024-09-26, 1403/07/05
Registrant information
Name
Pardis Garouee
Name of organization / entity
The University of Kharazmi
Country
Iran (Islamic Republic of)
Phone
+98 71 3632 7162
Email address
pardisgarouee@khu.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-11-09, 1403/08/19
Expected recruitment end date
2025-01-19, 1403/10/30
Actual recruitment start date
2024-11-09, 1403/08/19
Actual recruitment end date
2025-01-19, 1403/10/30
Trial completion date
2025-02-15, 1403/11/27
Scientific title
Comparison of the effect of adding pain neuroscience education to high-load strengthening exercises on clinical and functional outcomes of participants with hyper mobility spectrum disorder
Public title
"Effect of adding pain neuroscience education to high-load strengthening exercises on clinical and functional outcomes of participants with hyper mobility spectrum disorder"
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Women aged 18–65 years Generalized joint hypermobility (GJH) defined by Beighton score:– ≥ 5 for women aged ≤ 50 years– ≥ 4 for women aged > 50 years– or one point below the age-specific cutoff when the five-part questionnaire (5PQ) is positive (at least two positive items) Presence of one or more of the following secondary symptomatic musculoskeletal manifestations:– Musculoskeletal pain in at least one shoulder for a minimum of three months– and/or recurrent atraumatic joint dislocation or joint instability involving at least two joints (including at least one shoulder), defined as any of the following:• At least three atraumatic dislocations of the same shoulder• At least two atraumatic dislocations in two different joints (including at least one shoulder) occurring at separate times• Medically confirmed joint instability in at least two joints (including at least one shoulder) not related to trauma
Exclusion criteria:
Clinically suspected referred pain from the cervical spine Systemic inflammatory rheumatic disease Heritable connective tissue disorders (e.g., Marfan, Stickler, or Loeys–Dietz syndromes) Neurological disorders Pregnancy, childbirth within the previous 12 months, or plans to become pregnant during the study Corticosteroid injection into the affected shoulder within the previous 3 months Shoulder surgery within the previous 12 months Inability to communicate verbally Inability or unwillingness to comply with the study protocol or provide informed consent
Age
From 18 years old to 65 years old
Gender
Female
Phase
N/A
Groups that have been masked
  • Outcome assessor
Sample size
Target sample size: 45
Actual sample size reached: 45
Randomization (investigator's opinion)
Randomized
Randomization description
Eligible participants were randomly allocated in a 1:1:1 ratio to one of three groups using numbers from 1 to 45 prepared in advance by the treating instructor and placed in sealed opaque envelopes in a box. The randomization sequence remained concealed until completion of each participant’s baseline assessment, at which point the corresponding envelope was opened. A project manager not involved in outcome assessment or treatment delivery oversaw allocation concealment.
Blinding (investigator's opinion)
Single blinded
Blinding description
This was a single-blind (assessor-blinded) trial. The outcome assessor who performed all baseline and post-intervention assessments remained blinded to group allocation throughout the study. Participants and the treating instructor could not be blinded due to the nature of the interventions (exercise and education). Participants were instructed not to disclose their group assignment during follow-up testing.
Placebo
Not used
Assignment
Parallel
Other design features
This was a single-blind (assessor-blinded), three-arm, parallel-group randomized controlled trial with a pre-test–post-test design. An a priori sample size calculation was performed using G*Power software for a repeated-measures ANOVA (group-by-time interaction as the effect of interest), assuming a medium effect size (Cohen’s f = 0.25), α = 0.05, 80% power, three groups and two measurement occasions. The required sample size was estimated at 42 participants; 45 participants (15 per group) were enrolled.

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of the Research Institute of Physical Education and Sport Sciences
Street address
3, 5th Alley, Mirem ad Street, Motahari Street, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1587958711
Approval date
2023-09-20, 1402/06/29
Ethics committee reference number
IR.SSRC.REC.1402.146

Health conditions studied

1

Description of health condition studied
Hypermobility spectrum disorder (HSD) with chronic shoulder symptoms / Shoulder hypermobility spectrum disorder
ICD-10 code
ICD-10 code description

Primary outcomes

1

Description
Shoulder-specific symptoms and functional disability
Timepoint
Baseline (before intervention) and immediately after the 16-week intervention
Method of measurement
Western Ontario Shoulder Instability Index questionnaire (21 items, total score ranging from 0 to 2100)

Secondary outcomes

1

Description
Shoulder pain intensity
Timepoint
Baseline (before intervention) and immediately after the 16-week intervention
Method of measurement
Numerical Pain Rating Scale (score range 0 to 10)

2

Description
Shoulder internal rotation muscle strength
Timepoint
Baseline (before intervention) and immediately after the 16-week intervention
Method of measurement
Hand-held dynamometer (force measured in kilograms)

3

Description
Shoulder external rotation muscle strength
Timepoint
Baseline (before intervention) and immediately after the 16-week intervention
Method of measurement
Hand-held dynamometer (force measured in kilograms)

4

Description
Shoulder internal rotation range of motion
Timepoint
Baseline (before intervention) and immediately after the 16-week intervention
Method of measurement
Universal goniometer (measured in degrees)

5

Description
Shoulder external rotation range of motion
Timepoint
Baseline (before intervention) and immediately after the 16-week intervention
Method of measurement
Universal goniometer (measured in degrees)

6

Description
Fear of movement
Timepoint
Baseline (before intervention) and immediately after the 16-week intervention
Method of measurement
Tampa Scale of Kinesiophobia-11 questionnaire

Intervention groups

1

Description
Intervention group: high-threshold strengthening exercises with pain neuroscience training. Three familiarization sessions (two weeks) with training approaches to deal with pain and how to implement exercises will be held in approximately three months. The first session is a group session for a duration of 30 minutes to an hour with a maximum of six participants in each group using a PowerPoint. The second session, which includes three explanatory videos (online). The third session includes a 30-minute one-on-one conversation that relates the personal needs of the participants and the content to the pain neuroscience education. The contents of this group are about the physiology of pain and the nerve endings of pain.
Category
Rehabilitation

2

Description
Control group: Control group: The subjects of this group receive information on anatomy, physiology, the importance of self-care and ergonomic recommendations of Pasture.
Category
Other

3

Description
Intervention group: High-threshold strength training: weight training for 16 weeks, training twice a week (individually supervised) in a fitness center, consisting of 60 minutes of training for the first session, 30 minutes for subsequent sessions, and once a week (unsupervised) is done in one's own home. Their training program includes five exercises for shoulder muscles. The exercise intensity model is progressive with decreasing patterns between increasing periods.
Category
Rehabilitation

Recruitment centers

1

Recruitment center
Name of recruitment center
Rayka GYM
Full name of responsible person
Pardis Garouee
Street address
Pasdaran Street - the beginning of 72 Alley
City
Shiraz
Province
Fars
Postal code
7185994343
Phone
+98 938 413 4786
Email
pgarouee@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
kharazmi University
Full name of responsible person
Pardis Garouee
Street address
Iman Junubi Street - 19 Alley - No. 158
City
Shiraz
Province
Fars
Postal code
7185994343
Phone
+98 938 413 4786
Email
pgarouee@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
No
Title of funding source
No external funding (Kharazmi University provided academic facilities)
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
kharazmi University
Full name of responsible person
Pardis Garouee
Position
Master student
Latest degree
Bachelor
Other areas of specialty/work
Corrective Exercises
Street address
Iman Junubi St, 19 Alley, No. 158
City
Shiraz
Province
Fars
Postal code
7185994343
Phone
+98 938 413 4786
Email
pgarouee@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Kharazmi University
Full name of responsible person
Pardis Garouee
Position
Student
Latest degree
Bachelor
Other areas of specialty/work
Corrective movements and pathology
Street address
Iman Junubi St,19 Alley, No. 158
City
Shiraz
Province
Fars
Postal code
7185994343
Phone
+98 71 3632 7162
Email
pgarouee@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Kharazmi University
Full name of responsible person
Pardis Garouee
Position
Master of Science
Latest degree
Bachelor
Other areas of specialty/work
Corrective movements and pathology
Street address
South Iman Street, No. 158, 19 Alley
City
Shiraz
Province
Fars
Postal code
7185994343
Phone
+98 71 3632 7162
Email
pgarouee@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...